IRONDisc Medicine, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$31M

Net Income

-$36M

EPS (Diluted)

$-44.88

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$507,000

Balance Sheet

Total Assets

$92M

Total Liabilities

$157M

Stockholders' Equity

-$64M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$322,000	+100.0%
Operating Income	-$31M	-$34M	+9.1%
Net Income	-$36M	-$41M	+11.9%

IRON FY 2021 Earnings — Disc Medicine, Inc. Revenue & Financial Results | Market Cap Arena